Zobrazeno 1 - 10
of 19
pro vyhledávání: '"V T, Lozovskiĭ"'
Autor:
V E, Ryzhenkov, A M, Chistiakova, Iu V, Frolova, V T, Lozovskiĭ, I Iu, Kameneva, L E, Vasil'eva
Publikováno v:
Patologicheskaia fiziologiia i eksperimental'naia terapiia. (4)
Models of experimental dyslipoproteinemias have been developed by using non-inbred rats (males and females) and guinea-pigs. Administration of cholesterol (C) with fats and supplementation of 4-hydroxy-6-methyl-2-thiouracil to male rats and that of C
Publikováno v:
Biulleten' eksperimental'noi biologii i meditsiny. 117(3)
Autor:
I A, Oleĭnik, A D, Denisenko, K K, Mirchuk, Iu I, Sedletskiĭ, V T, Lozovskiĭ, L E, Basil'eva, V F, Triufanov
Publikováno v:
Voprosy meditsinskoi khimii. 39(2)
The level of lipids and apolipoproteins was studied in the serum of patients with various degrees of obesity without hormonal impairments in order to find interrelationship between obesity and atherosclerosis development. 14 men and 42 women aged 19-
Autor:
A M, Chistiakova, Iu V, Frolova, V F, Triufanov, L E, Vasil'eva, V T, Lozovskiĭ, V E, Ryzhenkov
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 55(5)
Experiments on rats, guinea pigs and rabbits with experimental dyslipoproteinemia have revealed that the new water-soluble high-molecular weight polymers containing digitonin (ED) or a quaternary nitrogen atom (EA) have a more marked hypolipidemic ac
Publikováno v:
Ukrainskii biokhimicheskii zhurnal (1. 64(2)
A procedure of theoretical determination of the dependence of protein molecule charge on the medium pH has been developed. The suggested procedure allows calculating the protein pI value, the molecule charge at the definite pH value, as well as the c
Autor:
V E, Ryzhenkov, A M, Chistiakova, V F, Triufanov, L E, Vasil'eva, Iu V, Frolova, M A, Solov'eva, O V, Remezova, V T, Lozovskiĭ, M, Khanefel'd, V, Leonkhardt
Publikováno v:
Kardiologiia. 30(8)
The bile acid sequestering agent Vasosan P is a new form of pectin-enriched cholestyramine (20%), saccharose (5%) and sorbic acid (0.18%). In comparison with cholestyramine Vasosan P has a more marked hypolipidemic effect in experiment. Vasosan P is
Publikováno v:
Kardiologiia. 29(6)
Levels of some fractions of blood neutral lipids and lipoperoxides were compared in the families of patients with coronary heart disease. The patients and their relatives (including healthy ones) were found to show a statistically significant increas
Publikováno v:
Voprosy meditsinskoi khimii. 29(1)
In men with increase of age from senile to longevity content of total cholesterol was practically unaltered (182 and 184 mg/100 ml), concentration of cholesterol in LPHD was increased from 52 mg up to 58.3 mg/100 ml simultaneously with unaltered cont
Publikováno v:
Biofizika. 32(2)
Particle diameters of very low density lipoprotein (VLDL)--29.5, 36.3, 22.0; low density lipoprotein (LDL)--18.4, 19.0, 22.0; high density lipoprotein subclass 2 (HDL2)--8.5, 9.7, 15.0; and high density lipoprotein subclass 3 (HDL3)--7.2, 7.6, 14.4 n
Publikováno v:
Kardiologiia. 20(8)
It is established that low-density lipoproteins (LDLP) are present in the human vascular wall in the form of complexes with glycosaminoglycans. These complexes dissociate in an electric field and in salt solutions which are usually used for isolating